But there are plenty of losers — big ones. Just 10 S&P 500 companies — including Intel (INTC), Nike (NKE) and Boeing (BA) — lost $383.2 billion in market value this year, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge.
These losses are big enough to erode the market's gain. S&P 500 companies as a group added an astounding $11.7 trillion in market value this year.
The Biggest Loser: Intel
No other S&P 500 stock has lost money like Intel this year. The computer chipmaker's value has dropped $117.1 billion in 2024. No wonder the CEO stepped down.
Missing out on the AI boom, shares of Intel are down 56.3% this year. INTC's Relative Strength Rating is just 12. And analysts think the company's profit will fall an additional 112% this year. That's in stark contrast with Nvidia (NVDA), which has seen shares rise 193%.
Another huge loser this year is Nike. Shares of the sneaker maker are down 28% this year. That wipes out more than $48.5 billion. Nike's story is also one of missing out to rivals. Consumers are preferring shoes from Deckers (DECK) and On Holding (ONON). On Holding sports an RS Rating of 94; Nike's is a paltry 15.
The Boeing S&P 500 Stock Disaster
Talk about an S&P 500 stock that always seems to disappoint. Despite a near monopoly in passenger aircraft manufacturing, shares of Boeing are off 39% this year. That erases more than $39.4 billion in value.
Boeing, though, can't blame its competition. The problem is a bloated cost structure and poor quality control. The company's profit is seen falling 176% this year.
Don't expect to hear much bragging about these S&P 500 stocks at this year's holiday party.
Biggest S&P 500 Losers This Year
Based on lost market value
Company Ticker YTD change Market value lost (billions)
Intel INTC -56.3% -$117.1
Nike NKE -27.8% -$48.6
Boeing BA -39.3% -$39.4
Adobe ADBE -10.1% -$35.4
CVS Health CVS -26.5% -$28.6
United Parcel Service UPS -18.1% -$24.1
Estee Lauder EL -45.8% -$23.8
Lululemon Athletica LULU -33.1% -$22.5
Moderna MRNA -58.1% -$21.9
Humana HUM -37.1% -$21.7
source: www.investors.com
